Pittsburgh (June 1, 2022) - Infectious Disease (ID) Connect, an Infectious Disease telehealth and decision support healthcare technology company spun out of UPMC, raised an additional $5.45 million in May 2022. First Trust Capital Partners, LLC joins UPMC Enterprises...
PITTSBURGH (May 26, 2022) — A new study published in Open Forum Infectious Diseases suggests that a clinical decision support solution (CDSS) can dramatically decrease total antibiotic usage and improve inpatient workflow efficiency.
PITTSBURGH, PA, (September 9, 2021) – UPMC, a leading academic medical center, has implemented Infectious Disease Connect’s powerful platform for antimicrobial stewardship and infectious diseases (ID) decision support to centralize and improve ID treatment across the health system.
PITTSBURGH, PA, (September 7, 2021) – PITTSBURGH, P.A., (September 7, 2021) Dr. Rinaldi is a PharmD who spent seven years with Melinta Therapeutics and The Medicines Company from 2014 through 2021 and served as the infectious disease medical science liaison for the Eastern Great Lakes region. He was an infectious disease/antibiotic stewardship pharmacist and clinical pharmacy manager at Waterbury Hospital in Connecticut and was the clinical pharmacy specialist in surgery at Norwalk Hospital in Connecticut.
MOORESTOWN, N.J., (March 25, 2021) – Tabula Rasa HealthCare, Incâ (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, has partnered with Infectious Disease (ID) Connect, a leader in infectious diseases telemedicine and antimicrobial stewardship.
PITTSBURGH, Feb. 17, 2021 – Infectious Disease Connect Inc., a UPMC-backed company offering solutions to improve treatment of infectious diseases and antimicrobial stewardship, recently received top scores from KLAS Research, reflecting the quality of its services and high customer satisfaction.
